Ultra bright dimeric or polymeric dyes with spacing linker groups

US9851359B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9851359-B2
Application numberUS-201715481378-A
CountryUS
Kind codeB2
Filing dateApr 6, 2017
Priority dateApr 6, 2016
Publication dateDec 26, 2017
Grant dateDec 26, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compounds useful as fluorescent or colored dyes are disclosed. The compounds have the following structure (I): or a stereoisomer, tautomer or salt thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , L 1 , L 2 , L 3 , L 4 , M, m and n are as defined herein. Methods associated with preparation and use of such compounds are also provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound having the following structure (I): or a stereoisomer, salt or tautomer thereof, wherein: M is, at each occurrence, independently a fluorescent dye; L 1 is at each occurrence, independently either: i) an optional alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, heteroalkynylene or heteroatomic linker; or ii) a linker comprising a functional group capable of formation by reaction of two complementary reactive groups; L 2 and L 3 are, at each occurrence, independently an optional alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, heteroalkynylene or heteroatomic linker; L 4 is, at each occurrence, independently a polyethylene oxide linker; R 1 is, at each occurrence, independently H, alkyl or alkoxy; R 2 and R 3 are each independently H, OH, SH, alkyl, alkoxy, alkylether, heteroalkyl, —OP(═R a )(R b )R c , Q, or a protected form thereof, or L′; R 4 is, at each occurrence, independently OH, SH, O − , S − , OR d or SR d ; R 5 is, at each occurrence, independently oxo, thioxo or absent; R a is O or S; R b is OH, SH, O − , S − , OR d or SR d ; R c is OH, SH, O − , S − , OR d , OL′, SR d , alkyl, alkoxy, heteroalkyl, heteroalkoxy, alkylether, alkoxyalkylether, phosphate, thiophosphate, phosphoalkyl, thiophosphoalkyl, phosphoalkylether or thiophosphoalkylether; R d is a counter ion; Q is, at each occurrence, independently a moiety comprising a reactive group, or protected form thereof, capable of forming a covalent bond with an analyte molecule, a targeting moiety, a solid support or a complementary reactive group Q′; L′ is, at each occurrence, independently a linker comprising a covalent bond to Q, a linker comprising a covalent bond to a targeting moiety, a linker comprising a covalent bond to an analyte molecule, a linker comprising a covalent bond to a solid support, a linker comprising a covalent bond to a solid support residue, a linker comprising a covalent bond to a nucleoside or a linker comprising a covalent bond to a further compound of structure (I); m is, at each occurrence, independently an integer of zero or greater, provided that at least one occurrence of m is an integer of one or greater, such that the compound includes at least one L 4 ; and n is an integer of one or greater. 2. The compound of claim 1 , wherein the compound has the following structure (IA): wherein z is an integer from 2 to 100. 3. The compound of claim 2 , wherein z is an integer from 3 to 6. 4. The compound of claim 1 , wherein L 1 has one of the following structures: 5. The compound of claim 1 , wherein the compound has the following structure (IB): wherein: x 1 , x 2 , x 3 and x 4 are, at each occurrence, independently an integer from 0 to 6; and z is an integer from 2 to 100. 6. The compound of claim 5 , wherein x 1 and x 3 are each 0 at each occurrence, and x 2 and x 4 are each 1 at each occurrence. 7. The compound of claim 5 , wherein x 1 , x 2 , x 3 and x 4 are each 1 at each occurrence. 8. The compound of claim 1 , wherein R 4 is, at each occurrence, independently OH, O − or OR d , and R 5 is, at each occurrence, oxo. 9. The compound of claim 1 , wherein R 1 is, at each occurrence, H. 10. The compound of claim 1 , wherein R 2 and R 3 are each independently —OP(═R a )(R b )R c . 11. The compound of claim 10 , wherein R c is OL′. 12. The compound of claim 11 , wherein L′ is a heteroalkylene linker to: Q, a targeting moiety, an analyte molecule, a solid support, a solid support residue, a nucleoside or a further compound of structure (I). 13. The compound of claim 12 , wherein L′ comprises an alkylene oxide or phosphodiester moiety, or combinations thereof. 14. The compound of claim 13 , wherein L′ has the following structure: wherein: m″ and n″ are independently an integer from 1 to 10; R e is H, an electron pair or a counter ion; L″ is R e or a direct bond or linkage to: Q, a targeting moiety, an analyte molecule, a solid support, a solid support residue, a nucleoside or a further compound of structure (I). 15. The compound of claim 12 , wherein the targeting moiety is an antibody or cell surface receptor antagonist. 16. The compound of claim 10 , wherein R 2 or R 3 has one of the following structures: 17. The compound of claim 1 , wherein Q comprises a sulfhydryl, disulfide, activated ester, isothiocyanate, azide, alkyne, alkene, diene, dienophile, acid halide, sulfonyl halide, phosphine, α-haloamide, biotin, amino or maleimide functional group. 18. The compound of claim 17 , wherein O comprises a maleimide functional group. 19. The compound of claim 1 , wherein Q has one of the following structures: wherein each X is independently a halogen. 20. The compound of claim 1 , wherein m is, at each occurrence, independently an integer from 1 to 10. 21. The compound of claim 1 , wherein m is, at each occurrence, independently an integer from 1 to 5. 22. The compound of claim 1 , wherein n is an integer from 1 to 10. 23. The compound of claim 1 , wherein M is, at each occurrence, independently pyrene, perylene, perylene monoimide or 6-FAM or derivative thereof. 24. The compound of claim 1 , wherein M, at each occurrence, independently has one of the following structures: 25. The compound of claim 1 , wherein the compound has one of the following structures I-1 through I-60:

Assignees

Inventors

Classifications

  • G01N33/582Primary

    with fluorescent label · CPC title

  • with fluorescent label · CPC title

  • containing organic luminescent materials · CPC title

  • containing other specific dyes · CPC title

  • containing a perylene dye · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9851359B2 cover?
Compounds useful as fluorescent or colored dyes are disclosed. The compounds have the following structure (I): or a stereoisomer, tautomer or salt thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , L 1 , L 2 , L 3 , L 4 , M, m and n are as defined herein. Methods associated with preparation and use of such compounds are also provided.
Who is the assignee on this patent?
Sony Corp America, Sony Corp
What technology area does this patent fall under?
Primary CPC classification G01N33/582. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).